# Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis

> **NCT04822415** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 330 (actual)

## Conditions studied

- Symptomatic Irreversible Pulpitis

## Interventions

- **DRUG:** Mepivacaine
- **DRUG:** Articaine

## Key facts

- **NCT ID:** NCT04822415
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2021-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04822415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04822415, "Anaesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine With Symptomatic Irreversible Pulpitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04822415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*